There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
0 responses
1,238 views
0 reactions
|
by jon123
07-08-2015, 08:02 PM
|
|||
|
3 responses
2,381 views
0 reactions
|
by anna_m
07-06-2015, 12:02 AM
|
|||
|
2 responses
1,778 views
0 reactions
|
by AllSeq
07-03-2015, 08:16 AM
|
|||
|
4 responses
4,591 views
0 reactions
|
by LTJensen
07-03-2015, 07:08 AM
|
|||
|
0 responses
3,622 views
0 reactions
|
by dwhite31
07-02-2015, 01:13 PM
|
|||
|
2 responses
2,554 views
0 reactions
|
by JBKri
07-02-2015, 01:06 AM
|
|||
|
1 response
1,233 views
0 reactions
|
06-24-2015, 01:17 AM
|
|||
|
0 responses
859 views
0 reactions
|
by Ohad
06-22-2015, 08:34 AM
|
|||
|
6 responses
1,922 views
0 reactions
|
06-20-2015, 05:30 PM
|
|||
|
20 responses
33,434 views
0 reactions
|
by seqdx
06-18-2015, 12:14 AM
|
No topics found.
-
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...07-31-2026, 07:00 AM
-
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...09-01-2026, 05:41 AM -
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM